Biogen Inc

NAS : BIIB

USA·Healthcare·Drug Manufacturers

$232.65

+3.62 (+1.76%)Oct 16 close

Market Cap

$34.14B

Enterprise Value

$36.40B

P/E (TTM)

41.17

P/B

1.85

Net Cash / (Debt)

−$7.07B

52-Week Range

$146 — $235

5-Year Range

$113 — $318

Avg Volume (3M)

1.25M

Biogen Inc Evaluation Of Aducanumab Efficacy And Safety In Early Alzheimer's Disease Discussion at AD/PD Conference Call Transcript

2021-03-13Conference Presentations

Read the full earnings transcript with Waltermetrics Pro

The complete transcript text is available to Pro members.